A detailed history of Pathstone Family Office, LLC transactions in Haleon PLC stock. As of the latest transaction made, Pathstone Family Office, LLC holds 23,804 shares of HLN stock, worth $230,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,804
Holding current value
$230,898
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$7.85 - $8.94 $186,861 - $212,807
23,804 New
23,804 $198,000
Q1 2023

May 15, 2023

SELL
$7.57 - $8.37 $69,863 - $77,246
-9,229 Reduced 46.52%
10,609 $86,000
Q4 2022

Oct 23, 2023

BUY
$5.96 - $8.06 $54,087 - $73,144
9,075 Added 84.32%
19,838 $158,000
Q4 2022

Feb 13, 2023

BUY
$5.96 - $8.06 $12,212 - $16,514
2,049 Added 11.52%
19,838 $158,000
Q3 2022

Oct 23, 2023

BUY
$5.63 - $7.5 $60,595 - $80,722
10,763 New
10,763 $63,000
Q3 2022

Nov 14, 2022

BUY
$5.63 - $7.5 $100,152 - $133,417
17,789 New
17,789 $108,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.